USAR

SEC Filing Summary: Inflection Point Acquisition Corp. II (IPXX)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2024. The registrant, Inflection Point Acquisition Corp. II (IPXX), is a Cayman Islands special purpose acquisition company (SPAC) formed to effect a business combination. On August 21, 2024, the Company entered into a definitive Business Combination Agreement with USA Rare Earth, LLC (USARE). Upon closing, the Company will be renamed "USA Rare Earth, Inc." and domesticated in Delaware. The Company has not commenced commercial operations; its activities are limited to formation, the IPO, and pursuing the business combination.

Key Financial Metrics

Note: Net income is driven primarily by dividend income from marketable securities held in the Trust Account ($3.4M for Q3; $10.2M YTD), offset by operating expenses. The Company has no operating revenue.

Material Changes vs. Prior Period

• Trust Account Growth: The Trust Account balance increased from $258.97 million (Dec 31, 2023) to $269.14 million (Sep 30, 2024), an increase of approximately $10.17 million due to dividend income earned on U.S. government securities.
• Operating Expenses: Formation and operating costs for the three months ended September 30, 2024 ($1.92M) were significantly higher than the same period in 2023 ($0.42M), reflecting increased activity related to the USARE business combination.
• Related Party Debt: As of September 30, 2024, the Company has an outstanding convertible promissory note of $700,000 to the CEO, Michael Blitzer. This liability was not present in the prior year-end balance sheet.
• Shareholder Deficit: Accumulated deficit increased to $(15.60) million due to accretion of redeemable shares to redemption value, partially offset by net income.

Outlook, Risks, and Unusual Items

• Business Combination Status: The Company is actively pursuing the merger with USA Rare Earth. The transaction includes an earn-out structure where up to 10 million shares of New USARE Common Stock may be issued based on stock price milestones ($15.00 and $20.00) over a five-year period.
• Extension Proposal: The Company filed a proxy statement to extend the deadline to consummate a business combination from November 30, 2024, to August 21, 2025. A shareholder vote was scheduled for November 18, 2024.
• Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern. With only $141,201 in cash outside the Trust and a working capital deficit, the Company relies on the successful completion of the business combination or additional financing to meet obligations.
• Fee Reduction: A Fee Reduction Agreement was signed with underwriters Cantor Fitzgerald & Co., reducing the deferred underwriting fee from $13.1 million to a combination of cash ($2M-$4M) and equity, contingent on the deal closing.
• Risks: Risks include failure to consummate the business combination by the deadline, insufficient funds to operate, and geopolitical instability affecting global markets.

Investor Verification Checklist

• Extension Vote Outcome: Verify if shareholders approved the extension to August 2025, as failure to extend could force liquidation.
• Redemption Levels: Monitor the percentage of public shares redeemed in connection with the business combination, as this impacts the final capital structure and cash available to USARE.
• Debt Conversion Terms: Confirm the treatment of the $700,000 related-party note, which is partially being converted to Series A Preferred Stock upon closing.
• Underwriting Fee Settlement: Verify the final settlement of the deferred underwriting fee (cash vs. equity mix) as it affects post-merger dilution.
• Trust Account Liquidity: Ensure the Trust Account remains invested in permitted U.S. government securities and that the balance per share remains above the initial $10.05 threshold.